A regenerative treatment for your face with multiple benefits

Over time, we may feel we don’t look like we used to, that our face has started to sag and that our skin looks dull and tired. Sculptra® is a regenerative treatment—the first proven regenerative biostimulator—that can help with multiple different skin concerns.1-6

People who reported improvement in skin firmness 2 years after treatment7

89%

People who reported an improvement in skin radiance (glow) 2 years after treatment7

91%

Injectors who said patients had improvements in the appearance of wrinkles 2 years after treatment8

86%

Injectors who said patients’ jawline is still enhanced 2 years after treatment7

86%

Sculptra®

The first proven regenerative treatment

Sculptra® is the first proven regenerative biostimulator that can help us look and feel like ourselves again.1-7,9 By stimulating the production of our own collagen and elastin5,6,10-14, Sculptra® progressively makes our skin firmer and more radiant.7

Rejuvenated, firm and
radiant skin that lasts7,15,16

Stay true to you! Sculptra® works progressively by increasing your own collagen and elastin,5,6,10-14 with visible results already 1 month after treatment and with results that last for more than 2 years.7,15,16

THE SCIENCE BEHIND

Find a specialist

Achieve the look you envision by speaking to  
a healthcare practitioner today.

GET STARTED

Frequently asked questions

Skin trends

Maecenas sed purus eget ligula ornare tincidunt ut vel urna

More skin trends

References

1. Sculptra. Instructions for Use EU 2021. 2. Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners. Galderma. 2021. Available from: https://www.galderma.com/news/galderma-receives-fda-approvalnew-sculptra-label-offering-more-options-aesthetic-partners [Last accessed June 2024]. 3. Asius J, et al. US patent US 7,731,758 B22(010):2010. 4. Sanofi S.r.l. DEKRA EN ISO 13485:2016 Certificate. Certificate effective since: February 2023. 5. Zhang Y, et al. Regen Biomater 2021;8(5):rbab042.  6. Widgerow A, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 1–3 February 2024. 7. Hexsel D, et al. Dermatol Surg. 2020;46(8):1122–4.8. Vierkötter A, Krutmann J. Dermatoendocrinol. 2012;4(3):227–31. 9. Zhang S, Duan E. Cell Transplantation. 2018;27(5):729–38.10. Aziz J, et al. Skin Pharmacol Physiol. 2016;29(4):190–203. 11. Swift A, et al, Aesthet Surg J. 2021;41(10):1107–19. 12. Data on File (MA-54104). 13. Goldberg D, et al. Dermatol Surg. 2013;39(6):915–22. 14. Mest DR, Humble G. Dermatol. Surg. 2006;32(11):1336–45. 15. Bohnert K, et al. Plast Reconstr Surg 2019;45(5):718–24. 16. Filho CDSM, et al. Surg Cosmet Dermatol. 2013;5(4):345–50. 17. Fabi S, et al. Effectiveness and safety of correction of cheek wrinkles. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 26–28 January 2023. Paris, France. 18. Fabi S, et al. Skin movement and volume changes with poly-L lactic acid (PLLA-SCA) injectable implant. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 26–28 January 2023. Paris, France. 19. Data on file (MA-48331).

Always consult a healthcare professional for individualized treatment recommendations and to discuss important
safety information and risks associated with the use of the products.